Pretreatment radiomic imaging features combined with immunological indicators to predict targeted combination immunotherapy response in advanced hepatocellular carcinoma

Figure 3 Receiver operating characteristic curve of relative enhancement ratio. Receiver operating characteristic curve analysis relative enhancement ratio was used to predict the efficacy of tyrosine kinase inhibitors combined with programmed death-1 in patients with advanced hepatocellular carcinoma (area under receiver operating characteristic curve = 0.874). ROC: Receiver operating characteristic.